IXEKIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 16,569 adverse event reports in the FDA FAERS database where IXEKIZUMAB was used for Psoriasis.
Most Reported Side Effects for IXEKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 3,799 | 11.3% | 0 | 64 |
| Psoriasis | 2,818 | 8.4% | 9 | 162 |
| Drug ineffective | 2,759 | 8.2% | 6 | 113 |
| Injection site erythema | 2,144 | 6.4% | 1 | 27 |
| Injection site reaction | 1,701 | 5.1% | 1 | 42 |
| Injection site swelling | 1,615 | 4.8% | 1 | 27 |
| Incorrect dose administered | 1,032 | 3.1% | 1 | 2 |
| Covid-19 | 861 | 2.6% | 16 | 67 |
| Product dose omission issue | 832 | 2.5% | 1 | 15 |
| Therapy interrupted | 796 | 2.4% | 0 | 46 |
| Injection site pruritus | 772 | 2.3% | 0 | 10 |
| Rash | 717 | 2.1% | 1 | 78 |
| Arthralgia | 714 | 2.1% | 1 | 83 |
| Diarrhoea | 667 | 2.0% | 3 | 67 |
| Pain | 656 | 2.0% | 1 | 77 |
Other Indications for IXEKIZUMAB
Product used for unknown indication (10,759)
Psoriatic arthropathy (5,798)
Ankylosing spondylitis (795)
Rheumatoid arthritis (298)
Axial spondyloarthritis (129)
Pustular psoriasis (81)
Guttate psoriasis (57)
Arthritis (47)
Polyarthritis (44)
Palmoplantar pustulosis (40)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)
HUMIRA (6,346)